Showing results (1461-1470 of 3,525) with videos related to

Sort By:
Pageof 353
Thoracic Cancer|September 14, 2018
Clinicopathological characteristics and prognosis of thyroid cancer in northwest China: A population-based retrospective study of 2490 patientsMeiling Huang, Changjiao Yan, Hongliang Wei, et al.
Thoracic Cancer|August 21, 2018
Neutrophil-to-lymphocyte ratio after four weeks of nivolumab administration as a predictive marker in patients with pretreated non-small-cell lung cancerTakayuki Takeda, Mayumi Takeuchi, Masahiko Saitoh, et al.
Thoracic Cancer|June 5, 2019
The prognostic value of the preoperative albumin to alkaline phosphatase ratio in patients with non-small cell lung cancer after surgeryLianmin Zhang, Hua Zhang, Dongsheng Yue, et al.
Thoracic Cancer|June 12, 2019
Salvage treatment with anlotinib for advanced non-small cell lung cancerDi Wu, Jun Nie, Ling Dai, et al.
Thoracic Cancer|October 13, 2018
Value of the preoperative neutrophil-to-lymphocyte ratio as a prognostic factor for long-term survival in postoperative esophageal squamous cell carcinoma patientsGuang-Wen Xu, Han-Ran Wu, Ran Xiong, et al.
Thoracic Cancer|April 10, 2019
Continued administration of pembrolizumab for adenocarcinoma of the lung after the onset of fulminant type 1 diabetes mellitus as an immune-related adverse effect: A case reportRyuya Edahiro, Mikako Ishijima, Hiroyuki Kurebe, et al.
Thoracic Cancer|April 12, 2019
Successful treatment with nivolumab for SMARCA4-deficient non-small cell lung carcinoma with a high tumor mutation burden: A case reportTomoyuki Naito, Shigeki Umemura, Hiroshi Nakamura, et al.
Thoracic Cancer|October 21, 2021
Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genesXiayao Diao, Chao Guo, Lei Liu, et al.
Thoracic Cancer|September 28, 2021
Inflammation-nutritional markers of peripheral blood could predict survival in advanced non-small-cell lung cancer patients treated with PD-1 inhibitorsDan Pu, Qian Xu, Lai-Yan Zhou, et al.
Thoracic Cancer|September 29, 2021
Tolerability and efficacy of IMpower133 regimen modified for dialysis patients with extensive-stage small cell lung cancer: Two case reportsNaokazu Watari, Kakuhiro Yamaguchi, Takeshi Masuda, et al.
Pageof 353